Search

everythinglearnresearchcommunity

for

Search:↓

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

PCOS treatment should be personalized based on its type and the patient's reproductive goals.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

PCOS is a hormonal disorder causing symptoms like excess hair, acne, irregular periods, and fertility issues.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The combined therapy improved fertility in women with PCOS, especially in certain types.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Finasteride doesn't affect ovulation in normal women.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Women with different PCOS types have similar fertility treatment results.